Shares of The Cooper Companies, Inc. (NASDAQ:COO – Get Free Report) have received an average rating of “Hold” from the seventeen research firms that are presently covering the firm, MarketBeat reports. Three research analysts have rated the stock with a sell rating, six have given a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the company. The average 1-year target price among brokers that have issued a report on the stock in the last year is $81.6429.
COO has been the subject of a number of research analyst reports. BNP Paribas Exane dropped their price objective on Cooper Companies from $95.00 to $92.00 and set an “outperform” rating for the company in a report on Monday, June 8th. The Goldman Sachs Group set a $61.00 price target on Cooper Companies in a research report on Wednesday, May 27th. JPMorgan Chase & Co. dropped their price target on Cooper Companies from $80.00 to $71.00 and set a “neutral” rating for the company in a research note on Friday, June 5th. UBS Group began coverage on shares of Cooper Companies in a research report on Tuesday, July 28th. They set a “neutral” rating and a $75.00 price target on the stock. Finally, Piper Sandler set a $86.00 price objective on shares of Cooper Companies and gave the stock an “overweight” rating in a research note on Monday, June 1st.
Read Our Latest Stock Report on Cooper Companies
Cooper Companies Stock Performance
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently modified their holdings of COO. Avalon Trust Co bought a new position in Cooper Companies in the second quarter worth about $25,000. Root Financial Partners LLC grew its holdings in shares of Cooper Companies by 104.5% during the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock valued at $26,000 after purchasing an additional 162 shares during the last quarter. SJS Investment Consulting Inc. lifted its holdings in shares of Cooper Companies by 107.5% in the 1st quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock worth $26,000 after purchasing an additional 187 shares during the last quarter. Elevation Wealth Partners LLC lifted its holdings in shares of Cooper Companies by 1,136.4% in the 2nd quarter. Elevation Wealth Partners LLC now owns 408 shares of the medical device company’s stock worth $29,000 after purchasing an additional 375 shares during the last quarter. Finally, Continuum Advisory LLC acquired a new position in Cooper Companies during the 2nd quarter valued at approximately $30,000. 24.39% of the stock is owned by institutional investors and hedge funds.
About Cooper Companies
Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.
The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.
Further Reading
- Five stocks we like better than Cooper Companies
- 3 Under-the-Radar Defense Stocks With Record Backlogs
- This Korea ETF Has Soared, But the Rally May Not Be Over
- Why Guidewire’s Post-Earnings Plunge May Not Last
- Ride-Share Reckoning: Tesla Drives Into Uber’s Lane
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.
